ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Triphenylphosphine → 2-Oxo-N-(1,2,4-thiadiazol-5-yl)-3-((2-(2,2,2-trifluoroethyl)-1,2,3,4 tetrahydroisoquinolin-8-yl)methyl)-2,3-dihydrobenzo[d]oxazole-6-sulfonamide

HRID 920223
印刷

反応式

HRID 920223 の反応式
COC1C=C(OC)C=CC=1C[N:6]([C:20]1[S:24][N:23]=[CH:22][N:21]=1)[S:7]([C:10]1[CH:19]=[CH:18][C:13]2[NH:14][C:15](=[O:17])[O:16][C:12]=2[CH:11]=1)(=[O:9])=[O:8].[F:31][C:32]([F:47])([F:46])[CH2:33][N:34]1[CH2:43][CH2:42][C:41]2[C:36](=[C:37]([CH2:44]O)[CH:38]=[CH:39][CH:40]=2)[CH2:35]1.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1>C1COCC1>[O:17]=[C:15]1[N:14]([CH2:44][C:37]2[CH:38]=[CH:39][CH:40]=[C:41]3[C:36]=2[CH2:35][N:34]([CH2:33][C:32]([F:47])([F:31])[F:46])[CH2:43][CH2:42]3)[C:13]2[CH:18]=[CH:19][C:10]([S:7]([NH:6][C:20]3[S:24][N:23]=[CH:22][N:21]=3)(=[O:8])=[O:9])=[CH:11][C:12]=2[O:16]1
参加物実験手順後処理出典と根拠反応ノート

参加物

5

反応物 3

HCID 11776TriphenylphosphineHCID 89526014(2-(2,2,2-Trifluoroethyl)-1,2,3,4-tetrahydroisoquinolin-8-yl)methanolHCID 89526027N-(2,4-dimethoxybenzyl)-2-oxo-N-(1,2,4-thiadiazol-5-yl)-2,3-dihydrobenzo[d]oxazole-6-sulfonamide

生成物 1

HCID 1176292832-Oxo-N-(1,2,4-thiadiazol-5-yl)-3-((2-(2,2,2-trifluoroethyl)-1,2,3,4 tetrahydroisoquinolin-8-yl)methyl)-2,3-dihydrobenzo[d]oxazole-6-sulfonamide

試薬・触媒・溶媒 1

HCID 8028Tetrahydrofuran溶媒

実験手順

A solution of 1-5 (16.5 mg, 0.037 mmol) and 7-5 (9.02 mg, 0.037 mmol) in THF (368 μl) at RT was treated with PS-bound triphenylphosphine (1.84 mmol/g, 40.2 mg, 0.074 mmol), and DTBAD (16.94 mg, 0.074 mmol). After 30 min, LCMS showed complete consumption of SM. Filtered through Celite and concentrated in vacuo. Dissolved in 245 uL DCM, 123 uL TFA and stirred at RT. After 30 min, diluted with 1 mL MeOH, filtered through Celite and washed with 1 mL MeOH. Concentrated in vacuo and purified by reverse-phase HPLC (C18 column, 5-70% 0.1% TFA/CH3CN:0.1% TFA/H2O) to give 7-6 as an off-white solid. 1H NMR δ (ppm) (DMSO-d6): 8.48 (1H, s), 7.78 (1H, d, J=1.69 Hz), 7.67 (1H, dd, J=8.28, 1.72 Hz), 7.25 (1H, d, J=8.33 Hz), 7.14-7.09 (2H, m), 6.92 (1H, d, J=6.83 Hz), 5.00 (2H, s), 3.99 (3H, s), 3.54 (3H, d, J=12.20 Hz), 2.90 (2H, s). HRMS C21H19F3N5O4S2 [M+H] calc 526.0825, obs. 526.0806.

後処理

  1. customconsumption of SM
  2. filtrationFiltered through Celite
  3. concentrationconcentrated in vacuo
  4. dissolutionDissolved in 245 uL DCM
  5. waitAfter 30 min
  6. additiondiluted with 1 mL MeOH
  7. filtrationfiltered through Celite
  8. washwashed with 1 mL MeOH
  9. concentrationConcentrated in vacuo
  10. custompurified by reverse-phase HPLC (C18 column, 5-70% 0.1% TFA/CH3CN:0.1% TFA/H2O)

出典と根拠

ORDレコード
ord-c59ca463e4544dfc9c4ba55f2d32040a
出典データセット
uspto-grants-2016_03
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US09273040B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート